ANI Pharmaceuticals reported $196.2M in Operating Expenses for its fiscal quarter ending in June of 2025.


Operating Expenses Change Date
AbbVie USD 9.71B 96M Jun/2025
ANI Pharmaceuticals USD 196.2M 25.27M Jun/2025
Aurora Cannabis CAD 118.24M 66.26M Jun/2025
Canopy Growth CAD 94.22M 4.36M Jun/2025
Eli Lilly USD 8.54B 1.22B Jun/2025
Hikma Pharmaceutical USD 1.31B 63M Dec/2024
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Novartis USD 9.37B 782M Jun/2025
Perrigo USD 1B 36.2M Jun/2025
Sun Pharmaceuticals INR 104.14B 1.45B Jun/2025
Teva Pharmaceutical Industries USD 3.28B 95M Jun/2025